SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $186K invested in Salarius Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.01% more ownership

Funds ownership: 0.03% → 0.03% (+0.01%)

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$61.9K
2
+$19.8K
3
+$7.05K
4
UBS Group
UBS Group
Switzerland
+$1.67K

Top Sellers

1
-$43.2K
2
-$72
3
-$23
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$61.9K
2
$38K
3
$31.7K
4
$29.5K
5
$19.8K
6
$2.65K
7
$2.15K
8
$115
9
$90
10
$90
11
$29